Literature DB >> 10874164

In vitro control of organogenesis and body patterning by activin during early amphibian development.

M Asashima1, T Ariizumi, G M Malacinski.   

Abstract

In the process of amphibian development, an embryonic body plan is established through cell division, sequential gene expression, morphogenesis and cell differentiation. The mechanism of body patterning is complex and includes multiple induction events. Activin, a TGF-beta family protein, can induce several kinds of mesodermal and endodermal tissues in animal cap explants in a dose-dependent manner. In a recent study of the role of activin in organogenesis, we succeeded in raising a beating heart by treating animal caps with a high concentration of activin. Activin also participates in kidney organogenesis in combination with retinoic acid. An embryonic kidney induced by activin and retinoic acid in vitro can function in vivo when it is transplanted into a larva in which pronephros rudiments have already been removed. Further, the activin-treated animal caps clearly show organizer actions that are closely related to body patterning along the anteroposterior axis. These experiments will help to serve as a model system for understanding organogenesis and body patterning at the cellular and molecular levels.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2000        PMID: 10874164     DOI: 10.1016/s0305-0491(00)00195-4

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  8 in total

1.  A role for Vg1/Nodal signaling in specification of the intermediate mesoderm.

Authors:  Britannia M Fleming; Ronit Yelin; Richard G James; Thomas M Schultheiss
Journal:  Development       Date:  2013-04       Impact factor: 6.868

2.  Leukemia inhibitory factor as an anti-apoptotic mitogen for pluripotent mouse embryonic stem cells in a serum-free medium without feeder cells.

Authors:  Miho Furue; Tetsuji Okamoto; Yohei Hayashi; Hitoshi Okochi; Manabu Fujimoto; Yasufumi Myoishi; Takanori Abe; Kiyoshi Ohnuma; Gordon H Sato; Makoto Asashima; J Denry Sato
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 Jan-Feb       Impact factor: 2.416

3.  Activin A induces craniofacial cartilage from undifferentiated Xenopus ectoderm in vitro.

Authors:  Miho Furue; Yasufumi Myoishi; Yasuto Fukui; Takashi Ariizumi; Tetsuji Okamoto; Makoto Asashima
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-07       Impact factor: 11.205

4.  Modulation of activin A-induced differentiation in vitro by vascular endothelial growth factor in Xenopus presumptive ectodermal cells.

Authors:  Shiro Yoshida; Miho Furue; Kentaro Nagamine; Takanori Abe; Yasuto Fukui; Yasufumi Myoishi; Tomoyuki Fujii; Tetsuji Okamoto; Yuji Taketani; Makoto Asashima
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 Mar-Apr       Impact factor: 2.416

5.  Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma.

Authors:  Tangjian Li; Shengli Li; Di Chen; Bing Chen; Tao Yu; Fangyu Zhao; Qifeng Wang; Ming Yao; Shenglin Huang; Zhiao Chen; Xianghuo He
Journal:  Cancer Sci       Date:  2017-04-26       Impact factor: 6.716

6.  The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.

Authors:  Xiaoling Zhong; Marianne Pons; Christophe Poirier; Yanlin Jiang; Jianguo Liu; George E Sandusky; Safi Shahda; Attila Nakeeb; C Max Schmidt; Michael G House; Eugene P Ceppa; Nicholas J Zyromski; Yunlong Liu; Guanglong Jiang; Marion E Couch; Leonidas G Koniaris; Teresa A Zimmers
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-07-08       Impact factor: 12.910

7.  Tanshinone I attenuates fibrosis in fibrotic kidneys through down-regulation of inhibin beta-A.

Authors:  Ming Wu; Feng Yang; Di Huang; Chaoyang Ye
Journal:  BMC Complement Med Ther       Date:  2022-04-19

8.  Generation of functional eyes from pluripotent cells.

Authors:  Andrea S Viczian; Eduardo C Solessio; Yung Lyou; Michael E Zuber
Journal:  PLoS Biol       Date:  2009-08-18       Impact factor: 8.029

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.